Boris Draznin
Concepts (585)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin | 96 | 2013 | 2079 | 4.800 |
Why?
| Diabetes Mellitus | 15 | 2021 | 904 | 3.560 |
Why?
| Hyperglycemia | 10 | 2016 | 292 | 3.400 |
Why?
| Insulin Resistance | 32 | 2013 | 1072 | 2.890 |
Why?
| Phosphatidylinositol 3-Kinases | 17 | 2012 | 330 | 2.310 |
Why?
| Proto-Oncogene Proteins p21(ras) | 23 | 2006 | 229 | 2.230 |
Why?
| Adipocytes | 13 | 2008 | 188 | 1.980 |
Why?
| Hypoglycemic Agents | 14 | 2021 | 1008 | 1.930 |
Why?
| Receptor, Insulin | 26 | 2003 | 93 | 1.930 |
Why?
| Alkyl and Aryl Transferases | 14 | 2003 | 34 | 1.740 |
Why?
| Diabetes Mellitus, Type 2 | 16 | 2021 | 2096 | 1.710 |
Why?
| Blood Glucose | 24 | 2020 | 1821 | 1.670 |
Why?
| Insulin, Long-Acting | 4 | 2020 | 52 | 1.560 |
Why?
| Hyperinsulinism | 11 | 2009 | 103 | 1.370 |
Why?
| Calcium | 21 | 2007 | 1104 | 1.200 |
Why?
| Protein Prenylation | 11 | 2006 | 19 | 1.080 |
Why?
| Muscle, Smooth, Vascular | 8 | 2007 | 417 | 1.080 |
Why?
| Adipose Tissue | 19 | 2007 | 539 | 1.070 |
Why?
| Signal Transduction | 25 | 2012 | 4524 | 0.920 |
Why?
| Muscle, Skeletal | 11 | 2012 | 1472 | 0.920 |
Why?
| Hospitalization | 5 | 2016 | 1754 | 0.890 |
Why?
| Phosphorylation | 31 | 2013 | 1572 | 0.890 |
Why?
| Insulin Receptor Substrate Proteins | 15 | 2013 | 56 | 0.880 |
Why?
| Rats | 69 | 2007 | 4963 | 0.870 |
Why?
| Obesity | 15 | 2013 | 2514 | 0.780 |
Why?
| Insulin Glargine | 4 | 2014 | 73 | 0.730 |
Why?
| Cytosol | 16 | 1994 | 208 | 0.720 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 71 | 0.710 |
Why?
| Inpatients | 3 | 2013 | 380 | 0.700 |
Why?
| Monosaccharide Transport Proteins | 9 | 2003 | 45 | 0.700 |
Why?
| Animals | 106 | 2013 | 31837 | 0.690 |
Why?
| Epidemics | 1 | 2021 | 69 | 0.690 |
Why?
| Glucose | 25 | 2006 | 897 | 0.640 |
Why?
| Proteins | 15 | 2001 | 912 | 0.630 |
Why?
| Myocytes, Smooth Muscle | 3 | 2006 | 236 | 0.610 |
Why?
| Physicians, Primary Care | 1 | 2021 | 222 | 0.610 |
Why?
| Dietary Fats | 5 | 2012 | 287 | 0.590 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2020 | 3248 | 0.580 |
Why?
| Deoxyglucose | 10 | 2008 | 43 | 0.580 |
Why?
| Platelet-Derived Growth Factor | 4 | 2003 | 82 | 0.570 |
Why?
| Enzyme Inhibitors | 12 | 2007 | 752 | 0.570 |
Why?
| Endocrinology | 1 | 2018 | 69 | 0.560 |
Why?
| Adiponectin | 4 | 2009 | 213 | 0.550 |
Why?
| Enteral Nutrition | 3 | 2013 | 157 | 0.540 |
Why?
| 3T3-L1 Cells | 5 | 2008 | 31 | 0.540 |
Why?
| Insulin-Like Growth Factor I | 11 | 2005 | 286 | 0.530 |
Why?
| Phosphoproteins | 10 | 2007 | 299 | 0.520 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 75 | 0.520 |
Why?
| Islets of Langerhans | 17 | 1991 | 728 | 0.510 |
Why?
| Protein Kinases | 3 | 2008 | 307 | 0.500 |
Why?
| Somatostatin | 13 | 2001 | 52 | 0.500 |
Why?
| Academic Medical Centers | 1 | 2018 | 415 | 0.500 |
Why?
| Triglycerides | 3 | 2012 | 470 | 0.490 |
Why?
| Patient Care Planning | 1 | 2016 | 139 | 0.490 |
Why?
| Farnesyltranstransferase | 11 | 2009 | 21 | 0.480 |
Why?
| Humans | 65 | 2021 | 114935 | 0.480 |
Why?
| Insulin, Isophane | 2 | 2013 | 17 | 0.480 |
Why?
| Growth Hormone | 8 | 2007 | 103 | 0.480 |
Why?
| Dietary Carbohydrates | 3 | 2012 | 137 | 0.460 |
Why?
| Phosphates | 3 | 2007 | 158 | 0.460 |
Why?
| 3T3 Cells | 13 | 2007 | 140 | 0.460 |
Why?
| Cells, Cultured | 25 | 2008 | 3897 | 0.460 |
Why?
| Glucocorticoids | 2 | 2016 | 534 | 0.460 |
Why?
| Rats, Inbred Strains | 26 | 1992 | 366 | 0.460 |
Why?
| Liver | 15 | 2009 | 1634 | 0.440 |
Why?
| Guanosine Triphosphate | 12 | 2000 | 85 | 0.440 |
Why?
| Muscle Proteins | 4 | 2012 | 210 | 0.430 |
Why?
| Medically Uninsured | 1 | 2014 | 122 | 0.430 |
Why?
| Kinetics | 24 | 2012 | 1555 | 0.420 |
Why?
| Continuity of Patient Care | 2 | 2019 | 254 | 0.420 |
Why?
| Practice Guidelines as Topic | 2 | 2018 | 1400 | 0.420 |
Why?
| Cystic Fibrosis | 2 | 2012 | 956 | 0.410 |
Why?
| Sirtuin 1 | 1 | 2012 | 29 | 0.400 |
Why?
| Diabetes Mellitus, Experimental | 5 | 1992 | 162 | 0.400 |
Why?
| Decision Making | 2 | 2018 | 781 | 0.400 |
Why?
| Patient Preference | 1 | 2014 | 169 | 0.400 |
Why?
| Biphasic Insulins | 1 | 2011 | 3 | 0.400 |
Why?
| Muscles | 3 | 2004 | 322 | 0.400 |
Why?
| Patient Care Team | 1 | 2016 | 516 | 0.390 |
Why?
| Mice | 28 | 2009 | 14935 | 0.390 |
Why?
| Enzyme Activation | 10 | 2008 | 790 | 0.390 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 3 | 2007 | 54 | 0.390 |
Why?
| Insulin Lispro | 1 | 2011 | 35 | 0.390 |
Why?
| Cell Membrane | 18 | 2003 | 679 | 0.380 |
Why?
| Biomarkers | 3 | 2020 | 3418 | 0.370 |
Why?
| AMP-Activated Protein Kinases | 1 | 2012 | 175 | 0.370 |
Why?
| Atherosclerosis | 4 | 2019 | 342 | 0.370 |
Why?
| Patient Admission | 1 | 2012 | 175 | 0.370 |
Why?
| Methylprednisolone | 1 | 2011 | 82 | 0.360 |
Why?
| Thiazolidinediones | 2 | 2008 | 142 | 0.360 |
Why?
| Hospitals | 2 | 2013 | 581 | 0.360 |
Why?
| Quality Improvement | 2 | 2018 | 954 | 0.360 |
Why?
| Male | 54 | 2020 | 55663 | 0.350 |
Why?
| Receptors, Cell Surface | 12 | 1986 | 354 | 0.350 |
Why?
| Phosphoprotein Phosphatases | 4 | 1995 | 64 | 0.350 |
Why?
| Dose-Response Relationship, Drug | 9 | 2011 | 1856 | 0.350 |
Why?
| Blotting, Western | 9 | 2012 | 1151 | 0.350 |
Why?
| Epidermal Growth Factor | 6 | 1998 | 163 | 0.340 |
Why?
| Medicaid | 1 | 2014 | 407 | 0.340 |
Why?
| Adaptor Proteins, Signal Transducing | 5 | 2001 | 369 | 0.340 |
Why?
| Pituitary Gland, Anterior | 5 | 1988 | 39 | 0.340 |
Why?
| Phosphoric Monoester Hydrolases | 4 | 1994 | 54 | 0.340 |
Why?
| rhoA GTP-Binding Protein | 4 | 2003 | 73 | 0.330 |
Why?
| DNA-Binding Proteins | 5 | 2004 | 1317 | 0.330 |
Why?
| MAP Kinase Signaling System | 3 | 2006 | 276 | 0.330 |
Why?
| Adult | 19 | 2020 | 30608 | 0.320 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2001 | 127 | 0.320 |
Why?
| Oligonucleotides, Antisense | 1 | 2009 | 100 | 0.320 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 15 | 0.320 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 13 | 0.320 |
Why?
| Algorithms | 1 | 2016 | 1474 | 0.320 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 271 | 0.320 |
Why?
| Endothelium, Vascular | 2 | 2007 | 848 | 0.310 |
Why?
| Cyclic AMP | 9 | 1993 | 225 | 0.310 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 172 | 0.310 |
Why?
| Mitochondrial Diseases | 1 | 2008 | 77 | 0.300 |
Why?
| Transfection | 9 | 2008 | 870 | 0.300 |
Why?
| Leukocytes | 2 | 2006 | 277 | 0.290 |
Why?
| Diabetic Angiopathies | 2 | 2007 | 244 | 0.290 |
Why?
| Pregnancy Proteins | 2 | 2005 | 36 | 0.280 |
Why?
| Female | 28 | 2020 | 59580 | 0.280 |
Why?
| Early Growth Response Protein 1 | 2 | 2006 | 24 | 0.270 |
Why?
| Androstadienes | 5 | 2008 | 97 | 0.270 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 1183 | 0.270 |
Why?
| Middle Aged | 15 | 2020 | 26806 | 0.270 |
Why?
| Phosphoserine | 1 | 2006 | 33 | 0.270 |
Why?
| Cytoplasmic Granules | 6 | 1986 | 82 | 0.270 |
Why?
| src Homology Domains | 2 | 2003 | 33 | 0.270 |
Why?
| Fetal Macrosomia | 1 | 2006 | 58 | 0.270 |
Why?
| Fasting | 7 | 2005 | 242 | 0.270 |
Why?
| Organophosphonates | 2 | 1997 | 91 | 0.270 |
Why?
| Glyburide | 6 | 1988 | 35 | 0.260 |
Why?
| RNA, Messenger | 8 | 2006 | 2558 | 0.260 |
Why?
| Food Deprivation | 1 | 2006 | 24 | 0.260 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 46 | 0.260 |
Why?
| Physical Conditioning, Animal | 2 | 2006 | 195 | 0.260 |
Why?
| Fatty Acids | 2 | 2012 | 382 | 0.260 |
Why?
| Mitogens | 3 | 2001 | 58 | 0.260 |
Why?
| Transcription Factors | 5 | 2004 | 1530 | 0.250 |
Why?
| Transferases | 4 | 1997 | 28 | 0.250 |
Why?
| Diabetes, Gestational | 2 | 2006 | 281 | 0.240 |
Why?
| Fetal Blood | 1 | 2006 | 270 | 0.240 |
Why?
| In Vitro Techniques | 15 | 2003 | 1034 | 0.240 |
Why?
| Adaptor Proteins, Vesicular Transport | 3 | 2001 | 45 | 0.240 |
Why?
| Diet, Reducing | 1 | 2005 | 78 | 0.240 |
Why?
| Diabetes Complications | 2 | 2019 | 211 | 0.240 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 2004 | 40 | 0.240 |
Why?
| Protein Subunits | 4 | 2008 | 201 | 0.240 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 34 | 0.230 |
Why?
| Cell Line | 12 | 2008 | 2640 | 0.230 |
Why?
| ras Proteins | 2 | 2009 | 138 | 0.220 |
Why?
| Protein Kinase C | 3 | 1996 | 275 | 0.220 |
Why?
| Garlic | 1 | 2003 | 3 | 0.220 |
Why?
| Sulfinic Acids | 1 | 2003 | 7 | 0.210 |
Why?
| Cell Nucleus | 3 | 1995 | 554 | 0.210 |
Why?
| Metabolic Syndrome | 3 | 2013 | 323 | 0.210 |
Why?
| Up-Regulation | 1 | 2006 | 812 | 0.210 |
Why?
| Drug Synergism | 5 | 2003 | 316 | 0.210 |
Why?
| Cell Division | 4 | 2009 | 759 | 0.200 |
Why?
| Sodium-Potassium-Exchanging ATPase | 2 | 1992 | 44 | 0.190 |
Why?
| Caloric Restriction | 2 | 2012 | 90 | 0.190 |
Why?
| Plant Extracts | 1 | 2003 | 155 | 0.190 |
Why?
| Aged | 7 | 2020 | 19122 | 0.180 |
Why?
| Growth Substances | 2 | 1998 | 137 | 0.180 |
Why?
| Weight Loss | 1 | 2005 | 642 | 0.180 |
Why?
| Angiotensin II | 1 | 2000 | 90 | 0.180 |
Why?
| Fetal Diseases | 1 | 2001 | 147 | 0.180 |
Why?
| Nitrendipine | 7 | 1993 | 13 | 0.170 |
Why?
| Lysophospholipids | 1 | 2000 | 65 | 0.170 |
Why?
| Oxidative Stress | 1 | 2006 | 1084 | 0.170 |
Why?
| Gene Expression Regulation | 3 | 2012 | 2324 | 0.170 |
Why?
| Cattle | 6 | 2007 | 924 | 0.170 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1996 | 41 | 0.170 |
Why?
| Insulin Infusion Systems | 2 | 2012 | 297 | 0.170 |
Why?
| Deoxy Sugars | 2 | 1989 | 2 | 0.160 |
Why?
| Drug Prescriptions | 1 | 2021 | 239 | 0.160 |
Why?
| Aging | 5 | 1992 | 1621 | 0.160 |
Why?
| Young Adult | 6 | 2020 | 10478 | 0.160 |
Why?
| Receptor, IGF Type 1 | 1 | 1998 | 58 | 0.160 |
Why?
| GTP-Binding Proteins | 1 | 1999 | 139 | 0.150 |
Why?
| Fellowships and Scholarships | 1 | 2021 | 227 | 0.150 |
Why?
| Serine | 2 | 2008 | 126 | 0.150 |
Why?
| Pilot Projects | 2 | 2014 | 1372 | 0.150 |
Why?
| Cations | 1 | 1998 | 79 | 0.150 |
Why?
| Protein Tyrosine Phosphatases | 3 | 1996 | 147 | 0.150 |
Why?
| Retrospective Studies | 4 | 2016 | 12544 | 0.150 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2003 | 278 | 0.140 |
Why?
| Receptors, Somatostatin | 11 | 1986 | 24 | 0.140 |
Why?
| Time Factors | 7 | 2006 | 6125 | 0.140 |
Why?
| Hypertension | 3 | 2019 | 1059 | 0.140 |
Why?
| Fibroblasts | 6 | 2001 | 839 | 0.140 |
Why?
| Models, Organizational | 1 | 2018 | 140 | 0.140 |
Why?
| Life Style | 1 | 2019 | 430 | 0.140 |
Why?
| NF-kappa B | 1 | 2000 | 637 | 0.140 |
Why?
| Oncogene Protein v-akt | 2 | 2008 | 26 | 0.140 |
Why?
| Exocytosis | 5 | 1988 | 89 | 0.140 |
Why?
| Quality of Health Care | 1 | 2021 | 573 | 0.140 |
Why?
| 1-Methyl-3-isobutylxanthine | 6 | 1986 | 24 | 0.130 |
Why?
| Recombinant Proteins | 5 | 2001 | 1233 | 0.130 |
Why?
| Potassium | 7 | 1992 | 128 | 0.130 |
Why?
| Swine, Miniature | 2 | 2013 | 71 | 0.130 |
Why?
| Cardiovascular Agents | 1 | 2016 | 125 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 929 | 0.130 |
Why?
| United States | 5 | 2021 | 12211 | 0.130 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 146 | 0.130 |
Why?
| Calcium-Transporting ATPases | 2 | 1993 | 35 | 0.130 |
Why?
| Mice, Obese | 2 | 2009 | 53 | 0.120 |
Why?
| Somatomedins | 5 | 1981 | 29 | 0.120 |
Why?
| Rats, Sprague-Dawley | 5 | 2006 | 2211 | 0.120 |
Why?
| Breast Neoplasms | 2 | 2003 | 1870 | 0.120 |
Why?
| Treatment Outcome | 3 | 2018 | 9105 | 0.120 |
Why?
| Glycogen Synthase | 2 | 1991 | 7 | 0.120 |
Why?
| Placenta Growth Factor | 2 | 2005 | 22 | 0.120 |
Why?
| Glucose Transporter Type 4 | 3 | 2003 | 36 | 0.120 |
Why?
| Rats, Zucker | 2 | 2007 | 27 | 0.120 |
Why?
| Thinness | 2 | 2012 | 87 | 0.120 |
Why?
| Point-of-Care Systems | 1 | 2015 | 139 | 0.110 |
Why?
| Fatty Acid Synthases | 2 | 2006 | 23 | 0.110 |
Why?
| Inulin | 1 | 1993 | 6 | 0.110 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2018 | 498 | 0.110 |
Why?
| Monitoring, Physiologic | 1 | 2015 | 248 | 0.110 |
Why?
| Glucose Tolerance Test | 3 | 2009 | 343 | 0.110 |
Why?
| Referral and Consultation | 1 | 2018 | 634 | 0.110 |
Why?
| Education, Medical | 1 | 1996 | 222 | 0.110 |
Why?
| ras Guanine Nucleotide Exchange Factors | 5 | 1996 | 8 | 0.110 |
Why?
| GRB2 Adaptor Protein | 5 | 2001 | 12 | 0.100 |
Why?
| Mice, Transgenic | 4 | 2007 | 1953 | 0.100 |
Why?
| Guanosine Diphosphate | 4 | 1997 | 19 | 0.100 |
Why?
| Prognosis | 1 | 2020 | 3344 | 0.100 |
Why?
| Guanine Nucleotide Exchange Factors | 5 | 1996 | 55 | 0.100 |
Why?
| Cricetinae | 3 | 2001 | 254 | 0.100 |
Why?
| Insulin Antagonists | 2 | 2008 | 6 | 0.100 |
Why?
| Injections, Subcutaneous | 1 | 2012 | 134 | 0.100 |
Why?
| Models, Biological | 4 | 2007 | 1630 | 0.100 |
Why?
| Parenteral Nutrition | 1 | 2013 | 96 | 0.100 |
Why?
| Health Services Accessibility | 1 | 2018 | 765 | 0.100 |
Why?
| Mice, Inbred C57BL | 4 | 2009 | 4718 | 0.100 |
Why?
| Transcription, Genetic | 3 | 2012 | 1317 | 0.100 |
Why?
| ras GTPase-Activating Proteins | 3 | 1996 | 13 | 0.100 |
Why?
| Phospholipases A | 1 | 1991 | 101 | 0.100 |
Why?
| ErbB Receptors | 4 | 1996 | 561 | 0.100 |
Why?
| Renal Insufficiency | 1 | 2013 | 136 | 0.090 |
Why?
| Flavonoids | 2 | 2004 | 67 | 0.090 |
Why?
| Membrane Proteins | 2 | 1996 | 1022 | 0.090 |
Why?
| GTPase-Activating Proteins | 3 | 1996 | 71 | 0.090 |
Why?
| RNA | 2 | 2009 | 810 | 0.090 |
Why?
| Energy Metabolism | 3 | 2012 | 724 | 0.090 |
Why?
| PPAR gamma | 1 | 2012 | 183 | 0.090 |
Why?
| Chromones | 2 | 2004 | 35 | 0.090 |
Why?
| Isoenzymes | 1 | 1991 | 285 | 0.090 |
Why?
| Critical Illness | 1 | 2015 | 643 | 0.090 |
Why?
| Oncogene Protein p21(ras) | 3 | 1994 | 16 | 0.090 |
Why?
| Luciferases | 2 | 2000 | 142 | 0.090 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 65 | 0.090 |
Why?
| Reference Values | 5 | 2002 | 741 | 0.090 |
Why?
| Diet | 3 | 2013 | 1077 | 0.090 |
Why?
| Morpholines | 2 | 2004 | 102 | 0.090 |
Why?
| Ion Channels | 2 | 1988 | 123 | 0.090 |
Why?
| Genes, Reporter | 2 | 2000 | 257 | 0.090 |
Why?
| Genes | 1 | 1990 | 224 | 0.090 |
Why?
| Telemedicine | 1 | 2018 | 665 | 0.080 |
Why?
| Renal Dialysis | 1 | 2013 | 369 | 0.080 |
Why?
| Tyrosine | 2 | 2008 | 216 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2019 | 6364 | 0.080 |
Why?
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.080 |
Why?
| Cell Movement | 2 | 2003 | 867 | 0.080 |
Why?
| Aorta | 1 | 1991 | 390 | 0.080 |
Why?
| Lipid Metabolism | 1 | 2012 | 446 | 0.080 |
Why?
| Cyclosporins | 1 | 1988 | 58 | 0.080 |
Why?
| CHO Cells | 2 | 2001 | 138 | 0.080 |
Why?
| Patient Readmission | 1 | 2014 | 608 | 0.080 |
Why?
| Verapamil | 4 | 1988 | 32 | 0.080 |
Why?
| Biological Transport | 3 | 1998 | 372 | 0.080 |
Why?
| Erectile Dysfunction | 1 | 1988 | 38 | 0.080 |
Why?
| Patient Discharge | 1 | 2014 | 769 | 0.070 |
Why?
| Exercise Tolerance | 1 | 2009 | 213 | 0.070 |
Why?
| Liver Glycogen | 3 | 1986 | 17 | 0.070 |
Why?
| Gene Knockdown Techniques | 1 | 2008 | 299 | 0.070 |
Why?
| Calcium Channels | 1 | 1988 | 146 | 0.070 |
Why?
| Swine | 3 | 2013 | 701 | 0.070 |
Why?
| PPAR alpha | 1 | 2007 | 52 | 0.070 |
Why?
| Parathyroid Hormone | 3 | 1993 | 95 | 0.070 |
Why?
| Lovastatin | 3 | 1996 | 26 | 0.070 |
Why?
| Mevalonic Acid | 2 | 1997 | 7 | 0.070 |
Why?
| Fenofibrate | 1 | 2007 | 24 | 0.070 |
Why?
| Transcription Factor Pit-1 | 1 | 2007 | 24 | 0.070 |
Why?
| Sodium-Phosphate Cotransporter Proteins | 1 | 2007 | 10 | 0.070 |
Why?
| Prospective Studies | 2 | 2012 | 6218 | 0.070 |
Why?
| Farnesol | 2 | 1997 | 5 | 0.070 |
Why?
| Eating | 1 | 1990 | 347 | 0.070 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 184 | 0.070 |
Why?
| Hypoglycemia | 1 | 2011 | 386 | 0.070 |
Why?
| Recombinant Fusion Proteins | 2 | 2001 | 617 | 0.070 |
Why?
| Gene Expression | 1 | 2012 | 1422 | 0.070 |
Why?
| Genetic Therapy | 1 | 2008 | 258 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 87 | 0.070 |
Why?
| Prostheses and Implants | 1 | 1988 | 140 | 0.070 |
Why?
| Adenosine Triphosphate | 3 | 1993 | 431 | 0.070 |
Why?
| Mice, Knockout | 2 | 2005 | 2586 | 0.070 |
Why?
| Cell Fusion | 1 | 1986 | 50 | 0.070 |
Why?
| Proto-Oncogene Proteins c-raf | 2 | 1996 | 43 | 0.070 |
Why?
| Bucladesine | 3 | 1992 | 23 | 0.070 |
Why?
| RNA, Small Interfering | 1 | 2008 | 543 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 1215 | 0.070 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2006 | 15 | 0.070 |
Why?
| Organophosphorus Compounds | 2 | 1997 | 72 | 0.070 |
Why?
| Microscopy, Electron | 4 | 1989 | 410 | 0.070 |
Why?
| Macromolecular Substances | 3 | 1996 | 200 | 0.070 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2008 | 359 | 0.060 |
Why?
| Coated Pits, Cell-Membrane | 1 | 1985 | 4 | 0.060 |
Why?
| Heart | 1 | 2009 | 609 | 0.060 |
Why?
| Macaca mulatta | 1 | 2006 | 131 | 0.060 |
Why?
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 3 | 2001 | 10 | 0.060 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2001 | 10 | 0.060 |
Why?
| Activating Transcription Factor 1 | 2 | 1995 | 9 | 0.060 |
Why?
| Peptides | 2 | 1981 | 848 | 0.060 |
Why?
| Body Weight | 6 | 2002 | 868 | 0.060 |
Why?
| Interleukin-1 | 1 | 1989 | 966 | 0.060 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 262 | 0.060 |
Why?
| Basal Metabolism | 1 | 2005 | 46 | 0.060 |
Why?
| Hemodynamics | 1 | 2009 | 1014 | 0.060 |
Why?
| Theophylline | 1 | 1985 | 60 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 164 | 0.060 |
Why?
| Bacterial Proteins | 1 | 1990 | 739 | 0.060 |
Why?
| Endosomes | 1 | 1985 | 124 | 0.060 |
Why?
| Risk | 1 | 2007 | 815 | 0.060 |
Why?
| Colorado | 1 | 2014 | 4091 | 0.060 |
Why?
| Retroviridae Proteins, Oncogenic | 1 | 2003 | 10 | 0.060 |
Why?
| Pregnancy | 3 | 2006 | 5527 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 3 | 1993 | 399 | 0.060 |
Why?
| Blotting, Northern | 3 | 1995 | 193 | 0.060 |
Why?
| Arachidonic Acids | 3 | 1988 | 58 | 0.060 |
Why?
| Phosphorus Radioisotopes | 2 | 1993 | 27 | 0.050 |
Why?
| Breast | 1 | 2003 | 141 | 0.050 |
Why?
| Energy Intake | 2 | 2005 | 420 | 0.050 |
Why?
| Proto-Oncogene Proteins | 2 | 1996 | 611 | 0.050 |
Why?
| Hypothyroidism | 2 | 1980 | 65 | 0.050 |
Why?
| Disease Models, Animal | 4 | 2013 | 3549 | 0.050 |
Why?
| Placental Hormones | 1 | 2002 | 4 | 0.050 |
Why?
| Streptozocin | 2 | 1992 | 17 | 0.050 |
Why?
| Cell Differentiation | 2 | 2001 | 1699 | 0.050 |
Why?
| Receptors, Progesterone | 1 | 2003 | 319 | 0.050 |
Why?
| Carrier Proteins | 3 | 1980 | 696 | 0.050 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 797 | 0.050 |
Why?
| Fetal Weight | 1 | 2001 | 52 | 0.050 |
Why?
| Starvation | 1 | 1981 | 21 | 0.050 |
Why?
| Colforsin | 3 | 1991 | 44 | 0.050 |
Why?
| Receptors, Estrogen | 1 | 2003 | 372 | 0.050 |
Why?
| Transcriptional Activation | 2 | 2000 | 337 | 0.050 |
Why?
| Nitric Oxide Synthase | 1 | 2001 | 209 | 0.050 |
Why?
| Calmodulin | 3 | 1986 | 71 | 0.050 |
Why?
| Serum Response Factor | 1 | 2000 | 28 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2001 | 372 | 0.040 |
Why?
| Maternal-Fetal Exchange | 1 | 2001 | 151 | 0.040 |
Why?
| Disease Progression | 1 | 2007 | 2392 | 0.040 |
Why?
| Glucosamine | 1 | 2000 | 12 | 0.040 |
Why?
| Glycation End Products, Advanced | 1 | 2000 | 57 | 0.040 |
Why?
| Lysosomes | 1 | 1981 | 123 | 0.040 |
Why?
| Response Elements | 1 | 2000 | 83 | 0.040 |
Why?
| Adenoviridae | 1 | 2001 | 185 | 0.040 |
Why?
| Hypopituitarism | 1 | 1980 | 15 | 0.040 |
Why?
| Son of Sevenless Proteins | 2 | 1996 | 4 | 0.040 |
Why?
| Leptin | 1 | 2001 | 211 | 0.040 |
Why?
| Fura-2 | 2 | 1991 | 19 | 0.040 |
Why?
| Mice, Mutant Strains | 1 | 2000 | 272 | 0.040 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 193 | 0.040 |
Why?
| Body Composition | 3 | 2009 | 585 | 0.040 |
Why?
| Arachidonic Acid | 3 | 1988 | 117 | 0.040 |
Why?
| Muscle Denervation | 1 | 1999 | 9 | 0.040 |
Why?
| Endocrinologists | 1 | 2019 | 12 | 0.040 |
Why?
| Aurothioglucose | 1 | 1999 | 6 | 0.040 |
Why?
| Clenbuterol | 1 | 1999 | 3 | 0.040 |
Why?
| rab3 GTP-Binding Proteins | 1 | 1999 | 2 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 1999 | 8 | 0.040 |
Why?
| Dogs | 1 | 2000 | 337 | 0.040 |
Why?
| Ionomycin | 2 | 1989 | 24 | 0.040 |
Why?
| Sheep | 1 | 2001 | 764 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2000 | 855 | 0.040 |
Why?
| Fatty Acids, Nonesterified | 3 | 2009 | 151 | 0.040 |
Why?
| Vascular Endothelial Growth Factors | 1 | 1998 | 61 | 0.040 |
Why?
| Endothelial Growth Factors | 1 | 1998 | 50 | 0.040 |
Why?
| Ethanol | 1 | 1983 | 548 | 0.040 |
Why?
| Lymphokines | 1 | 1998 | 111 | 0.040 |
Why?
| Hyperlipidemias | 1 | 2019 | 122 | 0.040 |
Why?
| Diabetic Neuropathies | 1 | 2019 | 79 | 0.040 |
Why?
| Protein Phosphatase 2 | 2 | 1995 | 30 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2000 | 399 | 0.040 |
Why?
| Binding Sites | 2 | 1996 | 1176 | 0.040 |
Why?
| Prosencephalon | 2 | 1994 | 45 | 0.040 |
Why?
| Body Mass Index | 1 | 2005 | 1961 | 0.040 |
Why?
| Rats, Wistar | 1 | 1998 | 368 | 0.040 |
Why?
| Half-Life | 1 | 1997 | 141 | 0.040 |
Why?
| Magnesium | 1 | 1998 | 145 | 0.040 |
Why?
| Dinitrophenols | 3 | 1982 | 7 | 0.040 |
Why?
| Diabetic Retinopathy | 1 | 2019 | 149 | 0.040 |
Why?
| Physician's Role | 1 | 2019 | 198 | 0.040 |
Why?
| Growth Hormone-Releasing Hormone | 2 | 1988 | 27 | 0.040 |
Why?
| Fetus | 1 | 2001 | 701 | 0.040 |
Why?
| Phenytoin | 1 | 1977 | 13 | 0.040 |
Why?
| Accidental Falls | 1 | 2019 | 150 | 0.030 |
Why?
| Oxygen Consumption | 2 | 2009 | 588 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1996 | 7 | 0.030 |
Why?
| Protein Phosphatase 1 | 2 | 1993 | 28 | 0.030 |
Why?
| Immunosorbent Techniques | 1 | 1996 | 17 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1996 | 20 | 0.030 |
Why?
| Second Messenger Systems | 1 | 1996 | 32 | 0.030 |
Why?
| Neurons | 2 | 1994 | 1282 | 0.030 |
Why?
| Prediabetic State | 1 | 2019 | 220 | 0.030 |
Why?
| Nuclear Proteins | 1 | 2000 | 593 | 0.030 |
Why?
| Infant, Newborn | 1 | 2006 | 5035 | 0.030 |
Why?
| Diabetic Nephropathies | 1 | 2019 | 234 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2106 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 113 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 1998 | 499 | 0.030 |
Why?
| Phenotype | 1 | 2003 | 2817 | 0.030 |
Why?
| Genes, Immediate-Early | 1 | 1995 | 15 | 0.030 |
Why?
| Rats, Inbred F344 | 2 | 1986 | 241 | 0.030 |
Why?
| Immunoblotting | 1 | 1996 | 283 | 0.030 |
Why?
| Off-Label Use | 1 | 2015 | 51 | 0.030 |
Why?
| Immediate-Early Proteins | 1 | 1995 | 52 | 0.030 |
Why?
| Research Support as Topic | 1 | 1996 | 108 | 0.030 |
Why?
| Disease Management | 1 | 2019 | 563 | 0.030 |
Why?
| Trypsin | 2 | 1993 | 67 | 0.030 |
Why?
| Glycogen | 1 | 1995 | 51 | 0.030 |
Why?
| Sequence Deletion | 1 | 1995 | 168 | 0.030 |
Why?
| Peptide Mapping | 1 | 1994 | 60 | 0.030 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1994 | 11 | 0.030 |
Why?
| DNA | 2 | 1998 | 1351 | 0.030 |
Why?
| ras-GRF1 | 1 | 1993 | 2 | 0.030 |
Why?
| Receptor, ErbB-2 | 1 | 1996 | 301 | 0.030 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 486 | 0.030 |
Why?
| Mutation | 1 | 2004 | 3353 | 0.030 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1996 | 386 | 0.030 |
Why?
| Health Services Needs and Demand | 1 | 2015 | 244 | 0.030 |
Why?
| Intracellular Membranes | 2 | 1985 | 73 | 0.030 |
Why?
| Chloroquine | 2 | 1986 | 52 | 0.030 |
Why?
| Cell Cycle | 1 | 1996 | 544 | 0.030 |
Why?
| Thapsigargin | 1 | 1993 | 18 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 1993 | 36 | 0.030 |
Why?
| Thionucleotides | 1 | 1993 | 34 | 0.030 |
Why?
| Blood Pressure | 2 | 2009 | 1537 | 0.030 |
Why?
| Consensus | 1 | 2015 | 534 | 0.030 |
Why?
| Terpenes | 1 | 1993 | 21 | 0.030 |
Why?
| Phenols | 1 | 1993 | 82 | 0.030 |
Why?
| Research | 1 | 1996 | 395 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1996 | 372 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 1996 | 1988 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 345 | 0.030 |
Why?
| Hormones | 2 | 1984 | 133 | 0.030 |
Why?
| Phosphorylase a | 1 | 1992 | 1 | 0.030 |
Why?
| Mass Screening | 1 | 2019 | 1011 | 0.030 |
Why?
| Peptide Fragments | 1 | 1996 | 668 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2012 | 181 | 0.020 |
Why?
| Okadaic Acid | 1 | 1991 | 11 | 0.020 |
Why?
| Mesocricetus | 1 | 1991 | 30 | 0.020 |
Why?
| Ethers, Cyclic | 1 | 1991 | 7 | 0.020 |
Why?
| Vanadates | 1 | 1991 | 13 | 0.020 |
Why?
| Phospholipases A2 | 1 | 1991 | 76 | 0.020 |
Why?
| Cadaverine | 2 | 1982 | 2 | 0.020 |
Why?
| Densitometry | 1 | 1991 | 29 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1992 | 153 | 0.020 |
Why?
| Calorimetry | 1 | 2012 | 60 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 1991 | 133 | 0.020 |
Why?
| Dietary Proteins | 1 | 2012 | 123 | 0.020 |
Why?
| Wheat Germ Agglutinins | 1 | 1991 | 3 | 0.020 |
Why?
| Arteries | 1 | 2013 | 247 | 0.020 |
Why?
| Sodium | 1 | 1992 | 182 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 319 | 0.020 |
Why?
| Sodium Fluoride | 2 | 1981 | 15 | 0.020 |
Why?
| Membrane Potentials | 1 | 1991 | 249 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 17 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 59 | 0.020 |
Why?
| Food | 1 | 1992 | 160 | 0.020 |
Why?
| Japan | 1 | 1990 | 87 | 0.020 |
Why?
| Vasodilation | 1 | 2013 | 416 | 0.020 |
Why?
| Secretory Rate | 2 | 1987 | 16 | 0.020 |
Why?
| Homozygote | 1 | 1990 | 188 | 0.020 |
Why?
| Sphingosine | 1 | 1989 | 33 | 0.020 |
Why?
| Nonsuppressible Insulin-Like Activity | 2 | 1979 | 2 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 2007 | 995 | 0.020 |
Why?
| Body Fat Distribution | 1 | 2009 | 44 | 0.020 |
Why?
| Cross-Sectional Studies | 2 | 2009 | 4407 | 0.020 |
Why?
| Plethysmography | 1 | 2009 | 104 | 0.020 |
Why?
| Trifluoperazine | 2 | 1987 | 4 | 0.020 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 103 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2012 | 927 | 0.020 |
Why?
| Freeze Fracturing | 1 | 1988 | 7 | 0.020 |
Why?
| Hydrostatic Pressure | 1 | 1988 | 19 | 0.020 |
Why?
| Puberty | 1 | 2009 | 135 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2009 | 307 | 0.020 |
Why?
| Freezing | 1 | 1988 | 85 | 0.020 |
Why?
| Ethers | 1 | 1987 | 16 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2009 | 387 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 400 | 0.020 |
Why?
| Egtazic Acid | 1 | 1987 | 44 | 0.020 |
Why?
| Benzofurans | 1 | 1987 | 18 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2009 | 362 | 0.020 |
Why?
| Adolescent | 4 | 2009 | 17829 | 0.020 |
Why?
| Linear Models | 1 | 2009 | 770 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 1987 | 157 | 0.020 |
Why?
| Exercise Test | 1 | 2009 | 545 | 0.020 |
Why?
| Echocardiography | 1 | 2009 | 555 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 1952 | 0.020 |
Why?
| Digitonin | 1 | 1986 | 4 | 0.020 |
Why?
| Culture Techniques | 1 | 1986 | 78 | 0.020 |
Why?
| Glyceraldehyde | 1 | 1985 | 2 | 0.020 |
Why?
| DNA Primers | 1 | 2007 | 514 | 0.020 |
Why?
| Pronase | 1 | 1985 | 5 | 0.020 |
Why?
| Sonication | 1 | 1985 | 10 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1986 | 83 | 0.020 |
Why?
| Heart Rate | 1 | 2009 | 705 | 0.020 |
Why?
| Lipids | 1 | 2009 | 582 | 0.020 |
Why?
| Interleukin-6 | 1 | 2009 | 676 | 0.020 |
Why?
| Feedback | 1 | 1986 | 145 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 1729 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 1987 | 300 | 0.020 |
Why?
| Organoids | 1 | 1986 | 74 | 0.020 |
Why?
| Urea | 1 | 1985 | 68 | 0.020 |
Why?
| Golgi Apparatus | 1 | 1985 | 89 | 0.020 |
Why?
| Stimulation, Chemical | 1 | 1985 | 57 | 0.020 |
Why?
| Peptide Hydrolases | 1 | 1986 | 106 | 0.020 |
Why?
| Homeostasis | 1 | 1988 | 576 | 0.020 |
Why?
| Biopsy | 1 | 1988 | 1045 | 0.020 |
Why?
| Binding, Competitive | 1 | 1985 | 194 | 0.020 |
Why?
| Tissue Distribution | 1 | 1985 | 285 | 0.020 |
Why?
| Gold | 1 | 1985 | 106 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 642 | 0.010 |
Why?
| Chick Embryo | 2 | 1994 | 122 | 0.010 |
Why?
| Thyroxine | 2 | 1981 | 58 | 0.010 |
Why?
| Perfusion | 2 | 1981 | 150 | 0.010 |
Why?
| Endocytosis | 1 | 1984 | 151 | 0.010 |
Why?
| 2,4-Dinitrophenol | 1 | 1982 | 8 | 0.010 |
Why?
| Cycloheximide | 1 | 1982 | 54 | 0.010 |
Why?
| Colchicine | 1 | 1982 | 24 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1982 | 71 | 0.010 |
Why?
| Case-Control Studies | 1 | 2009 | 3008 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2002 | 21 | 0.010 |
Why?
| Deuterium | 1 | 1982 | 79 | 0.010 |
Why?
| Receptors, Somatomedin | 1 | 1981 | 3 | 0.010 |
Why?
| Nutrition Disorders | 1 | 1981 | 22 | 0.010 |
Why?
| Radioisotopes | 1 | 1981 | 28 | 0.010 |
Why?
| Purine Nucleotides | 1 | 1981 | 12 | 0.010 |
Why?
| Intracellular Fluid | 1 | 1981 | 27 | 0.010 |
Why?
| Biotransformation | 1 | 1981 | 50 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 1980 | 49 | 0.010 |
Why?
| Adenosine Diphosphate | 1 | 1980 | 81 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1981 | 512 | 0.010 |
Why?
| Follow-Up Studies | 1 | 1988 | 4427 | 0.010 |
Why?
| Statistics as Topic | 1 | 1980 | 294 | 0.010 |
Why?
| Inflammation | 1 | 2009 | 2485 | 0.010 |
Why?
| Growth Disorders | 1 | 1979 | 78 | 0.010 |
Why?
| 11-Hydroxycorticosteroids | 1 | 1977 | 1 | 0.010 |
Why?
| Child | 2 | 2009 | 18366 | 0.010 |
Why?
| Phosphotyrosine | 1 | 1996 | 33 | 0.010 |
Why?
| Kidney Failure, Chronic | 1 | 1981 | 488 | 0.010 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1995 | 34 | 0.010 |
Why?
| Genes, fos | 1 | 1995 | 33 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1996 | 503 | 0.010 |
Why?
| Neurites | 1 | 1994 | 43 | 0.010 |
Why?
| Protein Binding | 1 | 1980 | 1897 | 0.010 |
Why?
| Microinjections | 1 | 1994 | 77 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1994 | 164 | 0.010 |
Why?
| Antibodies | 1 | 1994 | 372 | 0.010 |
Why?
| Cell Survival | 1 | 1994 | 1022 | 0.010 |
Why?
| Base Sequence | 1 | 1995 | 2118 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1995 | 2791 | 0.010 |
Why?
| Hydroxymercuribenzoates | 1 | 1987 | 1 | 0.000 |
Why?
| Dantrolene | 1 | 1987 | 5 | 0.000 |
Why?
| Oleic Acids | 1 | 1987 | 10 | 0.000 |
Why?
| Oleic Acid | 1 | 1987 | 30 | 0.000 |
Why?
| Lipoxygenase Inhibitors | 1 | 1987 | 36 | 0.000 |
Why?
| Child, Preschool | 1 | 1980 | 9086 | 0.000 |
Why?
| Membrane Fluidity | 1 | 1984 | 10 | 0.000 |
Why?
| Diterpenes | 1 | 1984 | 31 | 0.000 |
Why?
| Glucagon | 1 | 1984 | 93 | 0.000 |
Why?
| Membrane Lipids | 1 | 1984 | 87 | 0.000 |
Why?
| Adenine Nucleotides | 1 | 1982 | 18 | 0.000 |
Why?
| Phospholipids | 1 | 1984 | 197 | 0.000 |
Why?
| Adenosine Triphosphatases | 1 | 1982 | 155 | 0.000 |
Why?
| Nephrectomy | 1 | 1981 | 149 | 0.000 |
Why?
| Propylthiouracil | 1 | 1979 | 2 | 0.000 |
Why?
| Hypophysectomy | 1 | 1979 | 15 | 0.000 |
Why?
| Puromycin | 1 | 1979 | 11 | 0.000 |
Why?
| Radioligand Assay | 1 | 1979 | 43 | 0.000 |
Why?
| Kidney | 1 | 1981 | 1184 | 0.000 |
Why?
|
|
Draznin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|